CD8A and small cell lung carcinoma: The research indicated that, compared to other subtypes, the SCLC-I subtype exhibited higher levels of CD8 + T cells, natural killer (NK) cells, macrophages, and B lymphocytes, along with increased expression of immune checkpoints and HLAs, illustrating superior responses to ICIs.